CHM's Pharmacovigilance Expert Advisory Group; PEAG

CHM's Pharmacovigilance Expert Advisory Group (PEAG)

The closing date is 13 February 2026

Please note that applications submitted to  will be considered only.

The Commission on Human Medicines (CHM) is looking to appoint one expert to the Pharmacovigilance Expert Advisory Group (PEAG).

The PEAG advises the CHM on all aspects of pharmacovigilance for human medicines (including herbal products) and vaccines. Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

The PEAG also advises the CHM and the Medicines and Healthcare products Regulatory Agency (MHRA) on the strategic direction of the Yellow Card Scheme – the UK system for collecting and monitoring information on suspected adverse effects and medicine‑related safety concerns, and provides advice to MHRA on public applications for access to Yellow Card data for scientific research.

We are looking for an experienced community/hospital pharmacist who can provide their specialism perspective on relevant UK clinical practice and medicine‑related matters. The applicant must be registered with the General Pharmaceutical Council (GPhC) and currently practising community/hospital pharmacist, preferably with an interest in medicines safety and management and patient safety.

The Medicines and Healthcare products Regulatory Agency enhances and improves the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.

For full details on job description, please refer to advert attached and visit:
Membership - Commission on Human Medicines -

To an application please email your application form, CV, completed monitoring form and declaration of interest form to: , quoting the position and reference PEAG
26-1 in the subject field.

• The Member must be able to demonstrate the qualities, skills and experience to meet all the essential criteria for appointment.
• Must be a pharmacist registered with the GPhC.
• Must be a currently practicing community/hospital pharmacist.
• Must be available and able to commit to attending 12 meetings per year and possibly provide comments when required outside of the scheduled meetings.
• Interest in medicines safety and management and patient safety.
• Recognised by peers as a leader in their field e.g., national academies and Royal Colleges.
• Skilled communicator including providing written comments on papers and presentations.
• Able to assimilate complex scientific information at short notice.
• Willing to develop a working knowledge and understanding of UK medicines regulatory framework and procedures.
• Maintain strict confidentiality with respect to the work of the PEAG.
• Willing to declare conflicts of interest and comply with the Code of Practice.
• Committed to the values of selflessness, integrity, objectivity, accountability, professionalism, impartiality and consistency.
• Have previous or current experience of committee membership.

Part‑time, flexible working, home or remote working.